Skip to main content
Premium Trial:

Request an Annual Quote

What About Us, Wonder iPS Cells

A post at Science Progress hopes to remind everyone that even though stem cells are currently getting a bit of glory that iPS cells may eventually be a key tool. The post points to an article in last week's Cell in which Rudolf Jaenisch and his colleagues made iPS cells from Parkinson's disease patients' fibroblast cells that lacked viral factors and to another article in Nature from Andras Nagy's group that used transposons instead of viruses to reprogram the cells. It adds, though, that to make sure all the "kinks in the reprogramming process" are worked out, "we need to research human cells going all the way back to the embryonic stem stage."

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.